8-K filed June 28, 2023, 7:59 PM ET ticker NPCE CIK 0001528287

leadership confidence high sentiment neutral materiality 0.75

NeuroPace CEO Michael Favet resigns; Joel Becker appointed as new CEO effective July 10, 2023

NeuroPace Inc

Michael Favet resigns as CEO and Board member effective July 10, 2023; will provide consulting services for 12 months at $600/hour.
Joel Becker appointed President and CEO effective July 10, 2023; also joins Board as Class I director through 2025 annual meeting.
Becker receives base salary of $520,000/year, target bonus of 75% of salary, and option grant of 380,424 shares vesting over 4 years.
Becker most recently served as President at Viking North Ventures; prior roles include Integer Holdings and St. Jude Medical.
Favet's unvested equity awards will be cancelled on August 1, 2023; vested options remain exercisable per award agreements.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Favet

Director

NPCE · NeuroPace Inc

Effective: 2023-07-10
Filed: June 28, 2023, 7:59 PM ET

On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors

Departed

Michael Favet

Chief Executive Officer

NPCE · NeuroPace Inc

Effective: 2023-07-10
Successor: Joel Becker
Filed: June 28, 2023, 7:59 PM ET

On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors

Appointed

Joel Becker

Director

NPCE · NeuroPace Inc

Effective: 2023-07-10
Filed: June 28, 2023, 7:59 PM ET

On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.

Appointed

Joel Becker

Chief Executive Officer

NPCE · NeuroPace Inc

Effective: 2023-07-10
Filed: June 28, 2023, 7:59 PM ET

On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Favet resigned as Director at NeuroPace Inc.

Action: resigned
Role: Director

Exact text from the filing

On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Favet resigned as Chief Executive Officer at NeuroPace Inc.

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

On June 27, 2023, Michael Favet resigned from his position as Chief Executive Officer of NeuroPace, Inc. and as a member of NeuroPace’s board of directors

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joel Becker was appointed as Director at NeuroPace Inc.

Action: appointed
Role: Director

Exact text from the filing

On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joel Becker was appointed as Chief Executive Officer at NeuroPace Inc.

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

On June 28, 2023, NeuroPace appointed Joel Becker as Chief Executive Officer and as a member of the Board, in each case effective as of the Separation Date.

View on SEC.gov

NeuroPace Inc filing history →

Source: SEC EDGAR

accession 0001193125-23-177492

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.